ATE290836T1 - Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern - Google Patents

Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern

Info

Publication number
ATE290836T1
ATE290836T1 AT97938007T AT97938007T ATE290836T1 AT E290836 T1 ATE290836 T1 AT E290836T1 AT 97938007 T AT97938007 T AT 97938007T AT 97938007 T AT97938007 T AT 97938007T AT E290836 T1 ATE290836 T1 AT E290836T1
Authority
AT
Austria
Prior art keywords
drug
vaginal
core
containing core
channel
Prior art date
Application number
AT97938007T
Other languages
English (en)
Inventor
Saleh Ismail Saleh
Harold Nash
C Wayne Bardin
Troy Harmon
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Application granted granted Critical
Publication of ATE290836T1 publication Critical patent/ATE290836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
AT97938007T 1996-07-31 1997-07-22 Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern ATE290836T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2379296P 1996-07-31 1996-07-31
US08/850,327 US5972372A (en) 1996-07-31 1997-05-02 Intravaginal rings with insertable drug-containing core
PCT/US1997/012777 WO1998004220A1 (en) 1996-07-31 1997-07-22 Intravaginal rings with insertable drug-containing core

Publications (1)

Publication Number Publication Date
ATE290836T1 true ATE290836T1 (de) 2005-04-15

Family

ID=26697614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97938007T ATE290836T1 (de) 1996-07-31 1997-07-22 Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern

Country Status (13)

Country Link
US (2) US5972372A (de)
EP (1) EP0862396B1 (de)
JP (1) JP3970936B2 (de)
CN (1) CN1154455C (de)
AT (1) ATE290836T1 (de)
AU (1) AU4043197A (de)
BR (1) BR9706802A (de)
CA (1) CA2232635C (de)
DE (1) DE69732760T2 (de)
DK (1) DK0862396T3 (de)
ES (1) ES2239363T3 (de)
PT (1) PT862396E (de)
WO (1) WO1998004220A1 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537566B1 (en) 1999-03-11 2003-03-25 John Alton Copland Compositions and methods for the non-invasive treatment of uterine fibroid cells
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
PL367961A1 (en) * 2001-08-31 2005-03-07 Schering Oy Drug delivery system
WO2003080018A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal matrix drug delivery devices
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
US8367098B2 (en) * 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
CA2523859C (en) 2003-04-29 2011-08-02 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
ES2442675T3 (es) * 2003-07-10 2014-02-12 Warner Chilcott (Ireland) Limited Dispositivos intravaginales de suministro de fármacos
DE602005026290D1 (de) * 2004-07-09 2011-03-24 Population Council Inc Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060185678A1 (en) * 2005-02-03 2006-08-24 Bronnenkant Lance J Devices for delivering agents to a vaginal tract
MX2008000874A (es) 2005-07-19 2008-04-04 Population Council Inc Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina.
EP1933810B1 (de) * 2005-08-11 2012-10-10 Massachusetts Institute of Technology Vorrichtung und verfahren für intravesikale wirkstofffreisetzung
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
CN101448452B (zh) * 2006-03-20 2012-07-18 特卫华妇女健康有限公司 挠性压缩的阴道内环、其制备和使用方法及其生产设备
US8399012B2 (en) 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
EP2037938A2 (de) * 2006-07-12 2009-03-25 Controlled Therapeutics (Scotland) Ltd. Arzneiabgabe-polymer mit clindamycin-hydrochloridsalz
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
WO2008021309A1 (en) * 2006-08-15 2008-02-21 Wyeth Imidazolidin-2-one derivatives useful as pr modulators
US20080045560A1 (en) * 2006-08-15 2008-02-21 Wyeth Pyrrolidine and related derivatives useful as PR modulators
WO2008021338A2 (en) * 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
KR20090110355A (ko) * 2007-01-19 2009-10-21 더 유니버시티 오브 유타 리서치 파운데이션 치료제 전달용 생분해성 질내 기구
EP2170276B1 (de) * 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginale arzneiabgabevorrichtungen zur abgabe von makromolekülen und wasserlöslichen arzneimitteln
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
PT2062569E (pt) * 2007-11-22 2011-07-25 Bayer Oy Sistema de administração vaginal
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
PT2249757T (pt) 2008-02-04 2017-11-15 Ferring Bv Anéis intravaginais monolíticos compreendendo progesterona e métodos de preparação e suas utilizações
CN102176931B (zh) * 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US20120070476A1 (en) * 2009-05-29 2012-03-22 Moench Thomas R Compositions and Methods for Inactivation of Pathogens at Genital Tract Surfaces
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
ES2401008T3 (es) 2009-06-26 2013-04-16 Taris Biomedical, Inc. Comprimidos farmacéuticos sólidos para dispositivos implantables para la administración de fármacos
IN2012DN00711A (de) * 2009-07-21 2015-06-19 Population Council Inc
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US20130096092A1 (en) 2010-06-10 2013-04-18 Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
BR112012032951A2 (pt) * 2010-06-22 2018-02-27 Teva Womens Health Inc dispositivo intravaginal e método de fazer um dispositivo intravaginal
CA2808276A1 (en) * 2010-08-20 2012-02-23 Teva Women's Health, Inc. Intravaginal devices, methods of making, and uses thereof
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CN103298519B (zh) 2010-11-12 2016-09-14 犹他大学研究基金会 用于受控式润滑剂传递的阴道内装置
SG191893A1 (en) 2011-01-10 2013-08-30 Taris Biomedical Inc Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
RU2598057C2 (ru) * 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
CN103747765B (zh) 2011-06-06 2016-04-06 橡冠科学研究院 采用芯吸释放窗口的药物递送装置
EP2749286B1 (de) 2011-08-26 2017-03-01 Universidad De Santiago De Chile Verwendung der nichtsteroidalen entzündungshemmer meloxicam und piroxicam in intravaginalringen zur unterbrechung des eisprungs bei frauen
KR102192603B1 (ko) 2011-09-14 2020-12-17 포사이트 비젼5, 인크. 안내 삽입물 장치 및 방법
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
TW201332585A (zh) * 2012-02-14 2013-08-16 Chemo Res S L 核鞘藥物遞送裝置
EP2641602A1 (de) 2012-03-23 2013-09-25 PregLem S.A. Verfahren zur Behandlung gynäkologischer Leiden
DE102012009057A1 (de) * 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
CA2884030C (en) 2012-09-03 2018-04-10 Ecosea Farming S.A. Reservoir-cage submersion system for the culture and/or containment of hydrobiological species
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
BR112015018701A2 (pt) 2013-02-05 2017-07-18 The Population Council Inc anel vaginal para dispensação de um polímero solúvel em água, e, método para fabricar um anel vaginal para dispensação de um polímero solúvel em água
EP2953595B1 (de) 2013-02-08 2020-03-11 Qpharma AB Eine intravaginalvorrichtung und ein verfahren um die diffusionsrate der wirkstoffe in der intravaginalvorrichtung zu verringern
CN105120746A (zh) * 2013-03-08 2015-12-02 里加利私人有限公司 阴道给药和/或诊断系统
SG11201507294WA (en) 2013-03-15 2015-10-29 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
BR112015025954A2 (pt) 2013-04-10 2017-07-25 Preglem Sa moduladores do receptor de progesterona para utilização na terapia de fibroides uterinos
LT3035991T (lt) 2013-08-19 2020-11-10 Taris Biomedical Llc Daugiablokiai vaistų vartojimo įtaisai
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
SE539540C2 (sv) * 2013-09-12 2017-10-10 Qpharma Ab Ett läkemedelsavgivningssystem för en eller flera aktiva beståndsdelar
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
EP3079659B1 (de) 2013-12-11 2020-10-28 Merck Sharp & Dohme B.V. Arzneimittelliefersystem zur verabreichung von virenbekämpfungsmitteln
US10143721B2 (en) 2014-01-28 2018-12-04 The Population Council, Inc. Combination product for the prevention of sexually transmitted infections
PT3125964T (pt) * 2014-04-01 2024-09-09 Poly Med Inc Contracetivo e dispositivo relacionado
US20150306230A1 (en) * 2014-04-28 2015-10-29 Celanese Acetate Llc Drug delivery vehicles comprising cellulose derivatives, starch derivatives, and combinations thereof
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
PL2982352T3 (pl) * 2014-06-28 2019-01-31 Laboratorios Andrómaco S.A. Krążek szyjki macicy zawierający progesteron do długotrwałego, przedłużonego i ciągłego uwalniania, stosowany w celu zapobiegania przed przedwczesnym porodem
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
EP3285850A1 (de) 2015-04-23 2018-02-28 TARIS Biomedical LLC Wirkstoffabgabevorrichtungen mit einer wirkstoffdurchlässigen komponente und verfahren
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
BR112020008231A2 (pt) 2017-10-27 2020-10-27 Renovia, Inc. dispositivos, sistemas e métodos para treinamento dos músculos do assoalho pélvico
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US10918649B2 (en) * 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11529308B2 (en) * 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
EP4051238A1 (de) * 2019-11-27 2022-09-07 Oak Crest Institute of Science Arzneimittelausgabevorrichtung mit verzögerter freisetzung
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
USD935018S1 (en) 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
US20240252428A1 (en) * 2021-05-07 2024-08-01 The Population Council, Inc. Methods of providing birth control

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
BE792502A (fr) * 1971-12-09 1973-06-08 Upjohn Co Nouvelles formes pharmaceutiques et leur procede de preparation
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4155991A (en) * 1974-10-18 1979-05-22 Schering Aktiengesellschaft Vaginal ring
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US3995633A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal Medicament dispensing device
US3991760A (en) * 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
JPS5339064U (de) * 1976-09-08 1978-04-05
US4286587A (en) * 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
US4250611A (en) * 1979-04-19 1981-02-17 Alza Corporation Process for making drug delivery device with reservoir
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4596576A (en) * 1984-10-12 1986-06-24 Akzo N.V. Release system for two or more active substances
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
FR2618329B1 (fr) * 1987-07-22 1997-03-28 Dow Corning Sa Procede de fabrication d'un anneau capable d'assurer la liberation d'un agent therapeutique, et anneau fabrique par ce procede
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
EP0862396A4 (de) 2000-09-06
DK0862396T3 (da) 2005-07-11
US6126958A (en) 2000-10-03
JP3970936B2 (ja) 2007-09-05
CA2232635C (en) 2002-09-17
BR9706802A (pt) 1999-08-31
CA2232635A1 (en) 1998-02-05
EP0862396A1 (de) 1998-09-09
US5972372A (en) 1999-10-26
PT862396E (pt) 2005-07-29
DE69732760D1 (de) 2005-04-21
AU4043197A (en) 1998-02-20
CN1154455C (zh) 2004-06-23
EP0862396B1 (de) 2005-03-16
ES2239363T3 (es) 2005-09-16
CN1198091A (zh) 1998-11-04
WO1998004220A1 (en) 1998-02-05
JPH11512965A (ja) 1999-11-09
MX9802349A (es) 1998-08-30
DE69732760T2 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
ATE290836T1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
US5694947A (en) Intravaginal delivery system
US4186742A (en) Contraceptive-antivenereal disease tampon
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
CA2119252A1 (en) Controlled porosity implantable primary lumen device
NZ234881A (en) Biphasic transdermal drug delivery device
CA2233753A1 (en) Drug delivery system for two or more active substances
SE8803087D0 (sv) A new method of treating erectile dysfunction
CA2222133A1 (en) Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
KR890700349A (ko) 피임 및 유방암 억제용 조성물 및 이의 제조방법
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
BRPI0015284B8 (pt) formulações de hidrocodona de liberação controlada
WO1998004220A9 (en) Intravaginal rings with insertable drug-containing core
CA2040914A1 (en) Treatment of erectile dysfunction
AU7949294A (en) Pernasal composition and pernasal preparation containing thesame
WO2000042942A3 (en) Buccal drug delivery system for use in male contraception
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
IE801903L (en) Drug delivery device
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
EP0873751A3 (de) Pharmazeutisches produkt zur anwendung auf der mukosa der gebärmutter
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
IE791966L (en) Microparticle drug delivery
MY124465A (en) Reduction of infarct volume using citicoline
GR900100489A (el) Συνθέσεις χρήσιμοι ως αντισυλληπτικά για άνδρες.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0862396

Country of ref document: EP